Sign in
ARDX Stock Price, Chart, Stats & News
Ardelyx, Inc.
Save
Ardelyx, Inc. (ARDX) does not currently pay a dividend.
844.84M
Market cap
–
Current P/E
10.37x
Forward P/E
ARDX chart
Fundamentals
Gross margin | 90.29% |
Operating margin | -10.06% |
Pretax margin | -14.89% |
Net margin | -15.12% |
Effective tax rate | -1.60% |
ROA | -12.25% |
ROE | -40.63% |
D/E | 1.27x |
Interest coverage ratio | -1.44x |
ARDX valuation
P/E | – |
P/S | 3.30x |
P/B | 8.00x |
P/CF | -31.42x |
P/FCF | -30.56x |
P/OCF | -31.42x |
PEG | 1.66x |
EV multiple | -41.15x |
About
Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor.
Similar securities
Based on sector and market capitalization
Report issue